SoftWave TRT, LLC (SWTRT) is a medical technology company that is developing advanced solutions specializing in shock wave therapy for better patient healing.
Founded in 2004 and headquartered in Woodstock, GA, SWTRT is committed to the scientific advancement of tissue healing and regeneration and the development of the most effective innovations to improve the quality of lives globally.
SWTRT has strong international presence with its German affiliate and manufacturer, MTS Medical UG (MTS).
SWTRT technology is used worldwide in the healthcare fields of orthopedics, traumatology, wound care, aesthetics and urology.
SoftWave TRT, LLC was co-founded in 2004 by CEO John Warlick and business partner Mark Gronowski. The two men combined their years of experience in lithotripsy, a medical procedure that uses shock waves to dissolve kidney stones and the predecessor technology to what we use today for extracorporeal shock wave therapy (ESWT), to form a new company–SoftWave.
SoftWave’s purpose was designated to extend the medical use of shockwaves from lithotripsy and urology to nerve and tissue regeneration, musculoskeletal pain and injuries, cosmetics, brain indications and likely many more indications that have yet to be discovered.
SoftWave is sometimes known as stemwave therapy. SoftWave TRT is the first and only supplier of unfocused shock waves in North America and continues to research and develop new uses for unfocused shock wave therapy today.
From chronic non-healing soft tissue wounds to chronic tendinopathies to myofascial syndrome, this technology is changing lives one softwave at a time. The SoftWave team is continually researching, testing, and educating so we can hit our goal of having SoftWave be available to anyone that needs to prevent or heal an injury — because no one should have to settle for living in pain or with a chronic injury. — John Warlick, co-founder and CEO